NZ189817A - Certain synergistic anti-thrombotic compositions utilizing ergot peptide alkaloid/heparin combinations - Google Patents

Certain synergistic anti-thrombotic compositions utilizing ergot peptide alkaloid/heparin combinations

Info

Publication number
NZ189817A
NZ189817A NZ789817A NZ78981779A NZ189817A NZ 189817 A NZ189817 A NZ 189817A NZ 789817 A NZ789817 A NZ 789817A NZ 78981779 A NZ78981779 A NZ 78981779A NZ 189817 A NZ189817 A NZ 189817A
Authority
NZ
New Zealand
Prior art keywords
heparin
combinations
synergistic anti
compositions utilizing
certain synergistic
Prior art date
Application number
NZ789817A
Inventor
D Welzel
H Buehlmann
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ189817A publication Critical patent/NZ189817A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
NZ789817A 1978-03-06 1979-03-05 Certain synergistic anti-thrombotic compositions utilizing ergot peptide alkaloid/heparin combinations NZ189817A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782809618 DE2809618A1 (en) 1978-03-06 1978-03-06 NEW THERAPEUTIC PREPARATION AND METHOD FOR THE PRODUCTION THEREOF

Publications (1)

Publication Number Publication Date
NZ189817A true NZ189817A (en) 1981-04-24

Family

ID=6033695

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ789817A NZ189817A (en) 1978-03-06 1979-03-05 Certain synergistic anti-thrombotic compositions utilizing ergot peptide alkaloid/heparin combinations

Country Status (15)

Country Link
JP (1) JPS54126736A (en)
BE (1) BE874626R (en)
CH (1) CH639271A5 (en)
CY (1) CY1298A (en)
DE (1) DE2809618A1 (en)
FR (1) FR2419070A2 (en)
GB (1) GB2015338B (en)
HK (1) HK81085A (en)
IE (1) IE48192B1 (en)
KE (1) KE3548A (en)
NL (1) NL7901702A (en)
NZ (1) NZ189817A (en)
PH (1) PH16800A (en)
SG (1) SG49185G (en)
ZA (1) ZA791032B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945636A1 (en) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach STABLE SOLUTIONS OF HYDRATED ERGOTAL CALOIDS OR YOUR SALTS AND HEPARIN OR ITS SALTS AND METHOD FOR THE PRODUCTION THEREOF
CH656533A5 (en) * 1982-12-10 1986-07-15 Sandoz Ag THERAPEUTIC PREPARATION CONTAINING HYDRATED ERGOTAL CALOIDS AND LOW MOLECULAR HEPARINE.
DE3343818A1 (en) * 1982-12-10 1984-06-14 Sandoz-Patent-GmbH, 7850 Lörrach Therapeutic product containing hydrogenated ergot alkaloids and heparin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE441142B (en) * 1975-12-04 1985-09-16 Sandoz Ag PROCEDURE FOR PREPARING A THERAPEUTIC PREPARATION WITH ANTITHROMOBOTIC PROPERTIES

Also Published As

Publication number Publication date
HK81085A (en) 1985-10-25
KE3548A (en) 1985-08-02
GB2015338A (en) 1979-09-12
JPS54126736A (en) 1979-10-02
BE874626R (en) 1979-09-05
FR2419070A2 (en) 1979-10-05
SG49185G (en) 1986-01-17
CY1298A (en) 1985-10-18
GB2015338B (en) 1982-08-18
PH16800A (en) 1984-03-01
DE2809618A1 (en) 1979-09-20
FR2419070B1 (en) 1982-08-06
CH639271A5 (en) 1983-11-15
IE48192B1 (en) 1984-10-31
ZA791032B (en) 1980-10-29
IE790701L (en) 1979-09-06
NL7901702A (en) 1979-09-10

Similar Documents

Publication Publication Date Title
AU520754B2 (en) Nasal ergot alkaloid compositions
DE3570597D1 (en) TRANSFERRIN-VINCA ALKALOID CYTOTOXIC COMPOSITIONS
DE3069287D1 (en) Preservative compositions
AU508628B2 (en) Ergot alkaloid compositions
PH17724A (en) Azepine derivatives and their anti-thrombotic compositions and methods
GB2110533B (en) Compositions containing alkaloid derivatives
GB8422868D0 (en) Additive compositions
AU511893B2 (en) Sun-protective compositions
GB2052259B (en) Synergistic tickicidal compositions
PH17823A (en) Smoking compositions
NZ189817A (en) Certain synergistic anti-thrombotic compositions utilizing ergot peptide alkaloid/heparin combinations
FR2523408B1 (en) TABLE SWEETENER COMPOSITIONS
AU5403179A (en) Ergot alkaloid slow-release compositions
DE3367722D1 (en) Smoking compositions
GB2150024B (en) Anthelmintic compositions
GB2035801B (en) Cephradine compositions
NZ191048A (en) 1-benzoyl-3-pyridinyl-urea derivatives isecticidal compositions
GB2041951B (en) Bituminous compositions
AU512782B2 (en) Compositions comprising heparin andan ergot alkaloid
ZA781410B (en) Synergistic compositions
GB1552096A (en) Antifriction compositions
PH16045A (en) Smoking compositions
PH13566A (en) Antihypertensive compositions
GB2125696B (en) Compositions containing quinoline derivatives
GB2084174B (en) Solvent compositions